Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering ...
MarketWatch (press release)
The company currently is developing products based on three platform technologies: ANTISENILIN® is Intellect's Alzheimer's beta amyloid monoclonal antibody platform technology, which underlies a product in Phase 3 clinical trials and is licensed to ...
Intellect Neurosciences Expands Its Immunotherapy Pipeline with New Technology ...PharmaLive.com (press release)

all 18 news articles »

CytoDyn completes production of FIV monoclonal antibodies
Pharmaceutical Business Review
CytoFeline is a monoclonal antibody developed for the treatment of Feline Immunodeficiency Virus (FIV). Up on the completion of antibody purification, CVM will determine the practicality of anti-LFA1 antibodies to lower viral loads in FIV-infected cats ...
CytoDyn Announces Plans to Move Forward with Next Stage of Research of ...SunHerald.com

all 3 news articles »

Intellect Neurosciences Expands Its Immunotherapy Pipeline with New Technology ...
MarketWatch (press release)
The patent applications are based on Intellect's discovery that chemically stabilized protein aggregates present in Huntington's and Parkinson's disease, among others, can be used as immunogens to produce monoclonal antibodies that selectively detect ...

and more »